Oclacitinib 10 years later: lessons learned and directions for the future.
Sign Up to like & getrecommendations! Published in 2023 at "Journal of the American Veterinary Medical Association"
DOI: 10.2460/javma.22.12.0570
Abstract: Oclacitinib was approved in the United States 10 years ago for the management of atopic dermatitis (AD) and allergic skin disease in dogs. Many studies and case reports have been published in the past 10… read more here.
Keywords: learned directions; oclacitinib years; later lessons; lessons learned ... See more keywords